Defibrillation testing and clinical outcomes after implantable cardioverter –defibrillator implantation in patients in atrial fibrillation at the time of implant: An analysis from the SIMPLE trial

The Shockless IMPLant Evaluation (SIMPLE) trial showed that defibrillation testing (DT) at the time of implantable cardioverter –defibrillator (ICD) implant did not improve shock efficacy or reduce mortality. There are no data regarding the risk of complications, including stroke, among patients with atrial fibrillation (AF) who undergo DT.

Source: Heart Rhythm - July 28, 2018 Category: Cardiology Authors: Stefan Bogdan, Michael Glikson, Stuart J. Connolly, Jia Wang, Stefan H. Hohnloser, Ursula Appl, Jorg Neuzener, Philippe Mabo, Xavier Vinolas, Frederick Gadler, Lieselot van Erven, Josef Kautzner, Brandi Meeks, Janice Pogue, Jeff S. Healey Source Type: research